START Dallas is a clinical research site located in Fort Worth, Texas, United States 76104.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
START Dallas has participated in 4 clinical trials with 4 currently active.
Therapeutic areas: Advanced Malignancies, Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS.
Sponsors: PharmaMar, Verastem, Inc., Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Texas · View every site in Fort Worth
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
START Dallas has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
START Dallas has 4 clinical trials on record, with 4 currently active. Their work covers Advanced Malignancies, Pancreatic Ductal Adenocarcinoma (PDAC), G12D Mutated KRAS.
START Dallas has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.